Benedi v. McNeil: $8.85 Million Tylenol Verdict Over a Missing Liver Warning
Patrick Malone won an $8.85 million verdict against the maker of Tylenol after a former White House aide lost his liver to a drug he took exactly as directed.
What happened
In February 1993, Antonio Benedi, a former special assistant to President George H.W. Bush, came down with the flu. He took Extra Strength Tylenol at the doses printed on the box, never more than the maximum. He also kept his usual habit of three or four glasses of wine with dinner. Within days he was in a coma.
By February 10 he was in the hospital, near death, his liver shutting down. Surgeons performed an emergency transplant to keep him alive. The drug he had taken for ordinary aches, in ordinary amounts, had poisoned his liver because he was a regular drinker. The label said nothing about that combination.
Patrick Malone, then with Stein, Mitchell & Mezines, represented Benedi at the 1994 trial in the U.S. District Court for the Eastern District of Virginia in Alexandria. The case turned on what McNeil knew. Evidence showed the company had collected scores of reports tying therapeutic doses of acetaminophen plus alcohol to liver injury, roughly 60 such reports by the end of 1992. McNeil argued that a virus, not its product, caused the failure, and that its warnings were adequate.
The jury rejected that defense. In October 1994 it awarded Benedi $7,855,000 in compensatory damages and $1 million in punitive damages, $8.85 million in all.
Under Virginia law, punitive damages are capped, and the trial court reduced the $1 million punitive award to the state maximum of $350,000. McNeil's parent, Johnson & Johnson, appealed the verdict. In 1995 the Fourth Circuit affirmed, finding ample evidence for the jury's conclusion that McNeil had negligently failed to warn of the risk. It was the first reported decision in which that court approved punitive damages in a product-liability case.
Years later, federal regulators required a warning about acetaminophen and alcohol on over-the-counter pain relievers. The immunosuppressant drugs that kept Benedi's new liver alive went on to damage his kidneys, and he needed a second transplant.
Sources
This account is drawn from contemporaneous public reporting and the court record.
- 1.ProPublica: Use Only as Directed (Tylenol)·Archived copy
- 2.Deseret News: Jury Awards $8.9 Million in Tylenol Suit·Archived copy
- 3.Journal of Law, Medicine & Ethics (Cambridge Core): Acetaminophen (Tylenol): Johnson & Johnson and Consumer Safety·Archived copy
- 4.Leagle: Benedi v. McNeil-P.P.C., Inc., 66 F.3d 1378 (4th Cir. 1995)
More proven verdicts from Patrick Malone & Associates, P.C.
All Patrick Malone & Associates, P.C. proven verdicts →A D.C. Superior Court jury awarded $8.35 million after an orthopedic surgeon failed to recognize the loss of blood flow to an 82-year-old patient's leg following a knee replacement, leaving the limb to die and require an above-knee amputation.
A Montgomery County jury found a Maryland dermatology practice liable for the death of 47-year-old attorney Richard Semsker, whose melanoma went untreated for two years.
A 40-year-old store manager was left permanently impaired after a radiologist dismissed signs of a carotid blockage on her MRI, and a D.C. jury awarded $5,774,156 for the malpractice that preceded her stroke.
A premature newborn suffered a permanent chemical burn and stunted growth in her right ankle after an IV line leaked caustic fluid into the surrounding tissue, and a District of Columbia jury awarded her $3.6 million.
Related product liability verdicts
Sullivan Papain was among the firms representing New York State against Philip Morris, R.J. Reynolds, Brown & Williamson, and Lorillard, securing a $25 billion recovery through the 1998 Master Settlement Agreement.
C. Steven Yerrid, the youngest of Florida's 11-lawyer 'Dream Team,' added racketeering and conspiracy charges that tripled the damages ceiling, helping the state secure what was then the largest civil settlement in American history against the tobacco industry.
As co-lead counsel in the federal Roundup multidistrict litigation and the first firm to sue Monsanto in 2015, Weitz and Luxenberg helped negotiate a $10.9 billion settlement resolving approximately 125,000 non-Hodgkin lymphoma claims against Bayer-owned Monsanto.
After fifteen years of litigation and three failed bankruptcy maneuvers by Johnson and Johnson subsidiaries, Ashcraft and Gerel attorneys R. Bryant McCulley and Michelle Parfitt helped negotiate a global, uncapped settlement of at least $5.5 billion covering approximately 76,000 ovarian-cancer claims.